Sacubitril/valsartan: a cardiovascular drug with pluripotential actions

被引：11

作者：

Chrysant, Steven G. ^{[1
]}

Chrysant, George S. ^{[2
]}

机构：

[1] Univ Oklahoma, Hlth Sci Ctr, 5700 Mistletoe Court, Oklahoma City, OK 73142 USA

[2] INTEGRIS Baptist Med Ctr, Oklahoma City, OK USA

来源：

CARDIOVASCULAR DIAGNOSIS AND THERAPY | 2018年 / 8卷 / 04期

基金：

英国科研创新办公室;

关键词：

RECEPTOR-NEPRILYSIN INHIBITOR; NATRIURETIC-PEPTIDE; HEART-FAILURE; DOUBLE-BLIND; SYSTOLIC HYPERTENSION; EJECTION FRACTION; ASIAN PATIENTS; LCZ696; EFFICACY; SAFETY;

D O I：

10.21037/cdt.2018.05.10

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：543 / 548

页数：6

共 25 条

[1]

COMPARISON OF CANDOXATRIL AND ATRIAL-NATRIURETIC-FACTOR IN HEALTHY-MEN - EFFECTS ON HEMODYNAMICS, SYMPATHETIC ACTIVITY, HEART-RATE-VARIABILITY, AND ENDOTHELIN [J].

ANDO, S ;

RAHMAN, MA ;

BUTLER, GC ;

SENN, BL ;

FLORAS, JS .

HYPERTENSION, 1995, 26 (06) :1160-1166

[2]

Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex [J].

Ashby, Emma L. ;

Miners, James S. ;

Kehoe, Patrick G. ;

Love, Seth .

JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (04) :1191-1203

[3]

Chandra A, 2018, JAMA CARDIOL

[4]

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study [J].

Cheung, Deanna G. ;

Aizenberg, Diego ;

Gorbunov, Vladimir ;

Hafeez, Kudsia ;

Chen, Chien-Wei ;

Zhang, Jack .

JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01) :150-158

[5]

Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan [J].

Chrysant, Steven G. .

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2017, 11 (07) :461-468

[6]

The Clinical Significance of N-terminal Pro-brain Natriuretic Peptide in Detecting the Residual Cardiovascular Risk in Hypertension and Other Clinical Conditions and in Predicting Future Cardiovascular Events [J].

Chrysant, Steven G. .

JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (08) :718-720

[7]

Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension [J].

Engeli, Stefan ;

Stinkens, Rudi ;

Heise, Tim ;

May, Marcus ;

Goossens, Gijs H. ;

Blaak, Ellen E. ;

Havekes, Bas ;

Jax, Thomas ;

Albrecht, Diego ;

Pal, Parasar ;

Tegtbur, Uwe ;

Haufe, Sven ;

Langenickel, Thomas H. ;

Jordan, Jens .

HYPERTENSION, 2018, 71 (01) :70-77

[8]

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi) [J].

Gu, Jessie ;

Noe, Adele ;

Chandra, Priya ;

Al-Fayoumi, Suliman ;

Ligueros-Saylan, Monica ;

Sarangapani, Ramesh ;

Maahs, Suzanne ;

Ksander, Gary ;

Rigel, Dean F. ;

Jeng, Arco Y. ;

Lin, Tsu-Han ;

Zheng, Weiyi ;

Dole, William P. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04) :401-414

[9]

Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction [J].

Ito, Sadayoshi ;

Satoh, Minoru ;

Tamaki, Yuko ;

Gotou, Hiromi ;

Charney, Alan ;

Okino, Naoko ;

Akahori, Mizuki ;

Zhang, Jack .

HYPERTENSION RESEARCH, 2015, 38 (04) :269-275

[10]

Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension [J].

Jordan, J. ;

Stinkens, R. ;

Jax, T. ;

Engeli, S. ;

Blaak, E. E. ;

May, M. ;

Havekes, B. ;

Schindler, C. ;

Albrecht, D. ;

Pal, P. ;

Heise, T. ;

Goossens, G. H. ;

Langenickel, T. H. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (02) :254-263

← 1 2 3 →